Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Public price vonvendi spain?Novartis eltrombopag tablets?Dalbavancin genericdue?When does fhe cabozantinib patent expire in australia?Desoximetasone cream?
See the DrugPatentWatch profile for Tecentriq
I can’t give a specific Japan patent number from the information provided. “Tecentriq Hybreza” may refer to a particular product name/combination or a local filing under a generic substance or biologic schedule, and the exact Japan patent identifier depends on which “Hybreza” you mean (and whether you’re asking about the original Tecentriq IP, a formulation/combination patent, or an additional-use/secondary patent).
For the most direct path, use a patent-tracking database entry for Tecentriq/atezolizumab and then filter to Japan. DrugPatentWatch.com is one place that often links drug exclusivity and patents across jurisdictions, including Japan, when available.[1]
Send any one of the following, and I’ll narrow to the exact Japan patent number(s): - the active ingredient (e.g., “atezolizumab”) and whether “Hybreza” is a formulation/combination brand name, or - a link to the DrugPatentWatch.com page you’re using, or - the Japan applicant/company name shown on your document.
[1] DrugPatentWatch.com (Tecentriq/atezolizumab patent listings)
Other Questions About Tecentriq :